American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Lotramin, Tinactin Spray Recall Issued Over Presence of Benzene October 4, 2021 Russell Maas Add Your Comments Following a series of sunscreen recalls issued after benzene was detected in various aerosol spray products, Bayer issuing a recall for Lotrimin and Tinactin antifungal sprays, indicating that the products also may contain dangerous levels of the cancer-causing chemical. The Lotramin and Tinactin spray recalls were announced by the FDA on October 1, after routine sample testing discovered benzene in over-the-counter the aerosol spray products used to treat fungus infection, athlete’s foot, and to treat itching, burning, cracking and scaling skin. The recall impacts all unexpired lots of Lotrimin and Tinactin sprays cans, but does not include lotion forms of the products. Among the products included are Lotrimin Anti-Fungal (AF) Athlete’s Foot Powder Spray, Lotrimin Anti-Fungal Jock Itch (AFJI) Athlete’s Foot Powder Spray, Lotrimin Anti-Fungal (AF) Athlete’s Foot Deodorant Powder Spray, Lotrimin AF Athlete’s Foot Liquid Spray, Lotrimin AF Athlete’s Foot Daily Prevention Deodorant Powder Spray, Tinactin Jock Itch (JI) Powder Spray, Tinactin Athlete’s Foot Deodorant Powder Spray, Tinactin Athlete’s Foot Powder Spray and Tinactin Athlete’s Foot Liquid Spray. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The over-the-counter aerosol products were manufactured by Bayer U.S. LLC and have lot numbers beginning with TN, CV or NAA, and were distributed between September 2018 and September 2021 to various retailers in the U.S., Puerto Rico, Canada and Mexico. According to the recall notice, Lotrimin and Tinactin aerosol sprays were found to contain levels of benzene, which is classified as a human carcinogen, and not an intended ingredient in any of Bayer Consumer Health products. Benzene is an industrial chemical that has been associated with the development of several fatal forms of cancer, leukemia and other conditions, such as AML, Chronic Myelogenous Leukemia (CML), Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia (HCL), Non-Hodgkin’s Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome (MDL), Myelofibrosis and Myeloid Metaplasia, Aplastic Anemia and Thrombocytopenic Purpura. Long-term side effects of benzene exposure have been proven to cause anemia, which is a condition that develops when your blood lacks enough healthy red blood cells or hemoglobin. Essentially, the chemical causes bone marrow not to produce enough red blood cells, which can damage an individual’s immune system. Federal regulators have determined long-term exposure to benzene can significantly impact blood cells, to the extent it causes cancer such as leukemia, which affects the blood-forming organs. Customers are being asked to stop using the recalled anti-fungal sprays immediately and to contact Bayer at 1-866-360-3266 for instructions on how to obtain a refund properly dispose of the products. Sunscreen Spray Benzene Concerns The recall was announced amid growing concerns surrounding benzene in aerosol spray products, including popular sunscreens sold under the Neutrogena, Aveeno and Coppertone brands. In May 2021, the on-line pharmacy Valisure issued a warning after detecting benzene in sunscreen and after-sun care products tested from their inventory, indicating that more than a quarter contained benzene levels that exceed the threshold that the FDA has established as a safety concern. A massive Johnson & Johnson Neutrogena and Aveeno sunscreen recall was issued a few months later, and last week a similar Coppertone sunscreen recall was issued after unsafe levels of benzene were detected. A growing number of sunscreen spray lawsuits have now been filed against manufacturers, each raising similar allegations that the company endangered consumers’ health by not warning them of the presence of benzene, which could lead to the development of cancer and other injuries. On September 24, the FDA issued a press release announcing plans to improve the quality, safety and effectiveness of over-the-counter sunscreen products, adding new requirements affecting the maximum sunscreen protection values (SPF), the active ingredients, labeling, testing requirements and numerous other requirements. Tags: Anemia, Bayer, Benzene, Cancer, Chemical, Lotramin, Tinactin More Lawsuit Stories Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL March 3, 2025 Study Finds Some Antidepressants Cause Cognitive Decline, Dementia and Fracture Risks March 3, 2025 American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices March 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025) Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024) Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)
American Law Institute Sets New Standards for Medical Malpractice, Less Focused on Customary Practices March 3, 2025
Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (Posted: today) Judge is calling for Depo-Provera lawyers to submit applications for MDL leadership by the end of the week, indicating that female attorneys should be adequately represented. MORE ABOUT: DEPO-PROVERA LAWSUITJudge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)Depo-Provera Lawyers Will Meet With MDL Judge For Initial Case Management Conference on Friday (02/18/2025)Side Effects of Combined Hormonal Contraceptives Carry Higher Blood Clot Risks Than Others: Study (02/18/2025)
Oxbryta Injury Lawsuit Over Discontinued Sickle Cell Disease Drug Set for Trial in June 2027 (Posted: 4 days ago) A federal judge has scheduled an Oxbryta lawsuit to go before a jury on June 7, 2027, which may be the first trial over side effects of the discontinued sickle cell disease drug. MORE ABOUT: OXBRYTA LAWSUITOxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (12/30/2024)Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (11/19/2024)Oxbryta Recall Lawsuits Claim Drug Manufacturer Knew About Fatality Risks for Years (11/08/2024)
Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties (Posted: 4 days ago) A federal judge has ordered lawyers involved in Bard PowerPort lawsuits to submit a joint proposal for preparing the first cases for bellwether trials by March 18. MORE ABOUT: BARD POWERPORT LAWSUITE. Coli Infection Was Caused by AngioDynamics SmartPort Port Catheter, Lawsuit Alleges (03/03/2025)AngioDynamics Seeks to Have Many Chemo Port Lawsuits Dismissed, Arguing Lawsuits Were Filed Too Long After Implant Failed (02/25/2025)AngioDynamics Vortex Port Lawsuit Filed Over Infection, Need for Surgical Removal (02/18/2025)